Primary Non-Adherence After Intensification of Antihypertensive Medication: The Path Study
View Full PaperWhy the study?
Does non-adherence to a new antihypertensive prescription affect blood pressure control at 4 months in adult patients with uncontrolled hypertension?
Population
207 adult patients with a documented history of hypertension and an office BP >=140/90 mmHg, median age 70…
Comparison
New prescription for antihypertensive medication vs Patients without therapy intensification, or…
Design
Cohort
Follow-up
4 months
Key result
Primary non-adherence occurred in 8% (95% CI 4-14%) of patients receiving a new antihypertensive prescription, and systolic BP reduction did not differ significantly based on adherence (p=0.19).
Authors
Loading...
Non-adherence to new antihypertensives may not limit early BP control; leaves open whether targeted interventions improve outcomes in larger cohorts.
Cohort (n=207)
No
Does non-adherence to a new antihypertensive prescription affect blood pressure control at 4 months in adult patients with uncontrolled hypertension?
Primary non-adherence to newly prescribed antihypertensive medications occurs in 8% of patients, increasing to 24% by 4 months, highlighting a significant barrier to effective hypertension management.
Saville et al. (2026) conducted a cohort in Hypertension (n=207). New prescription for antihypertensive medication was evaluated on Primary non-adherence (not dispensing a prescription within 30 days) (95% CI 4-14). Primary non-adherence occurred in 8% (95% CI 4-14%) of patients receiving a new antihypertensive prescription, and systolic BP reduction did not differ significantly based on adherence (p=0.19).